Press Releases

TALLC in the News

July 7, 2020

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

June 3rd, 2020

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

CONTACT US

Phone: 514 883 3447

Email: info@tallcinc.com

NEWS

TALLC Corporation Announces Grant of New SmartCelle Patent for
Enhanced Ocular Delivery of TA-A001

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

TALLC Launches New Ophthalmology Drug WebSite:

https://www.tallcinc.com

TALLC Inc. is an emerging ophthalmology company developing novel mechanism medicines to treat acute and chronic conditions of the eye. Visit our website to learn more about TA-A001,…https://lnkd.in/dTjZ8Nx

Load More...
TALLC Innovation in Vision

© TALLC Inc. 2020